Germering, Germany

Daniel Vitt

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Planegg-Martinsried, DE (2004)
  • Germering, DE (2012 - 2024)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Daniel Vitt**

Introduction

Daniel Vitt, a distinguished inventor located in Germering, Germany, has made significant contributions to the field of pharmaceutical innovation. With 12 patents to his name, he has been at the forefront of research aimed at combating viral diseases and addressing inflammatory responses.

Latest Patents

Among his noteworthy inventions, Daniel's recent patents stand out for their potential impact on global health. One of his latest innovations is the patent for **Vidofludimus**, which is designed for the treatment and prevention of viral diseases. This compound specifically inhibits dihydroorotate dehydrogenase (DHODH), proving to be especially relevant for combating infections caused by various coronaviruses, including SARS-CoV-2 and its mutated versions.

Another significant patent involves the development of **calcium salt polymorphs** that serve as anti-inflammatory, immunomodulatory, and anti-proliferative agents. This invention highlights the creation of a unique white crystalline polymorph A of the calcium salt of a compound that inhibits DHODH. Its distinct structure can be characterized by an X-ray powder diffraction pattern with specified peaks, underscoring its innovative composition aimed at treating ailments linked to DHODH inhibition.

Career Highlights

Throughout his career, Daniel has worked with notable companies such as Immunic AG and 4SC AG, where he has played a pivotal role in advancing pharmaceutical research. His expertise in the field is not only reflected in his patents but also in his impact on the organizations he has been a part of.

Collaborations

Collaboration has been key to Daniel's success. He has worked closely with talented individuals such as Hella Kohlhof and Andreas Mühler, contributing to the richness and diversity of ideas that drive innovation. These collaborations foster a dynamic environment where creativity and expertise merge to bring transformative inventions to life.

Conclusion

Daniel Vitt stands as a prominent figure in the realm of innovation, particularly in the pharmaceutical sector. His advancements in treatment protocols, particularly targeting viral infections and inflammatory processes, underline the importance of his work. As he continues to innovate and collaborate, his contributions will undoubtedly shape the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…